These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23459475)

  • 21. Clade 2.3.4.4 H5 North American Highly Pathogenic Avian Influenza Viruses Infect, but Do Not Cause Clinical Signs in, American Black Ducks (
    Spackman E; Prosser DJ; Pantin-Jackwood M; Stephens CB; Berlin AM
    Avian Dis; 2019 Jun; 63(2):366-370. PubMed ID: 31251539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.
    Stoner TD; Krauss S; DuBois RM; Negovetich NJ; Stallknecht DE; Senne DA; Gramer MR; Swafford S; DeLiberto T; Govorkova EA; Webster RG
    J Virol; 2010 Oct; 84(19):9800-9. PubMed ID: 20660186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The I222V neuraminidase mutation has a compensatory role in replication of an oseltamivir-resistant influenza virus A/H3N2 E119V mutant.
    Simon P; Holder BP; Bouhy X; Abed Y; Beauchemin CA; Boivin G
    J Clin Microbiol; 2011 Feb; 49(2):715-7. PubMed ID: 21106781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.
    Choi WS; Jeong JH; Kwon JJ; Ahn SJ; Lloren KKS; Kwon HI; Chae HB; Hwang J; Kim MH; Kim CJ; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of infection by H5N2 highly pathogenic avian influenza viruses in healthy wild waterfowl.
    Gaidet N; Cattoli G; Hammoumi S; Newman SH; Hagemeijer W; Takekawa JY; Cappelle J; Dodman T; Joannis T; Gil P; Monne I; Fusaro A; Capua I; Manu S; Micheloni P; Ottosson U; Mshelbwala JH; Lubroth J; Domenech J; Monicat F
    PLoS Pathog; 2008 Aug; 4(8):e1000127. PubMed ID: 18704172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Permissive changes in the neuraminidase play a dominant role in improving the viral fitness of oseltamivir-resistant seasonal influenza A(H1N1) strains.
    Abed Y; Pizzorno A; Bouhy X; Boivin G
    Antiviral Res; 2015 Feb; 114():57-61. PubMed ID: 25512229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural Investigations and Binding Mechanisms of Oseltamivir Drug Resistance Conferred by the E119V Mutation in Influenza H7N9 Virus.
    Ugbaja SC; Mtambo SE; Mushebenge AG; Appiah-Kubi P; Abubakar BH; Ntuli ML; Kumalo HM
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model.
    Hurt AC; Nor'e SS; McCaw JM; Fryer HR; Mosse J; McLean AR; Barr IG
    J Virol; 2010 Sep; 84(18):9427-38. PubMed ID: 20631138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consecutive natural influenza a virus infections in sentinel mallards in the evident absence of subtype-specific hemagglutination inhibiting antibodies.
    Globig A; Fereidouni SR; Harder TC; Grund C; Beer M; Mettenleiter TC; Starick E
    Transbound Emerg Dis; 2013 Oct; 60(5):395-402. PubMed ID: 22816511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of avian influenza viruses of the N6 subtype to the neuraminidase inhibitor oseltamivir.
    Stoner TD; Krauss S; Turner JC; Seiler P; Negovetich NJ; Stallknecht DE; Frase S; Govorkova EA; Webster RG
    Antiviral Res; 2012 Mar; 93(3):322-9. PubMed ID: 22252168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Indonesian clade 2.1 highly pathogenic influenza A(H5N1) viruses with N294S and S246N neuraminidase substitutions which further reduce oseltamivir susceptibility.
    McKimm-Breschkin JL; Barrett S; Wong FYK; Pudjiatmoko ; Azhar M; Selleck P; Davies KR; Hartaningsih N; McGrane J
    Antiviral Res; 2018 May; 153():95-100. PubMed ID: 29574145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combinatorial effect of two framework mutations (E119V and I222L) in the neuraminidase active site of H3N2 influenza virus on resistance to oseltamivir.
    Richard M; Ferraris O; Erny A; Barthélémy M; Traversier A; Sabatier M; Hay A; Lin YP; Russell RJ; Lina B
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2942-52. PubMed ID: 21422222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. THE PATHOGENESIS OF CLADE 2.3.4.4 H5 HIGHLY PATHOGENIC AVIAN INFLUENZA VIRUSES IN RUDDY DUCK (OXYURA JAMAICENSIS) AND LESSER SCAUP (AYTHYA AFFINIS).
    Spackman E; Prosser DJ; Pantin-Jackwood MJ; Berlin AM; Stephens CB
    J Wildl Dis; 2017 Oct; 53(4):832-842. PubMed ID: 28513330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The significance of naturally occurring neuraminidase quasispecies of H5N1 avian influenza virus on resistance to oseltamivir: a point of concern.
    Schaduangrat N; Phanich J; Rungrotmongkol T; Lerdsamran H; Puthavathana P; Ubol S
    J Gen Virol; 2016 Jun; 97(6):1311-1323. PubMed ID: 26935590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral Susceptibilities of Avian Influenza A(H5), A(H7), and A(H9) Viruses Isolated in Japan.
    Takashita E; Morita H; Nagata S; Shirakura M; Fujisaki S; Miura H; Takayama I; Arita T; Suzuki Y; Yamaoka M; Tanikawa T; Tsunekuni R; Mine J; Sakuma S; Uchida Y; Shibata A; Iwanaka M; Kishida N; Nakamura K; Kageyama T; Watanabe S; Hasegawa H;
    Jpn J Infect Dis; 2022 Jul; 75(4):398-402. PubMed ID: 34980710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of age on avian influenza viral shedding in mallards (Anas platyrhynchos).
    Costa TP; Brown JD; Howerth EW; Stallknecht DE
    Avian Dis; 2010 Mar; 54(1 Suppl):581-5. PubMed ID: 20521698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675.
    Molla A; Kati W; Carrick R; Steffy K; Shi Y; Montgomery D; Gusick N; Stoll VS; Stewart KD; Ng TI; Maring C; Kempf DJ; Kohlbrenner W
    J Virol; 2002 Jun; 76(11):5380-6. PubMed ID: 11991966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioluminescence-based neuraminidase inhibition assay for monitoring influenza virus drug susceptibility in clinical specimens.
    Marjuki H; Mishin VP; Sleeman K; Okomo-Adhiambo M; Sheu TG; Guo L; Xu X; Gubareva LV
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5209-15. PubMed ID: 23917311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant.
    Zhang J; Murugan NA; Tian Y; Bertagnin C; Fang Z; Kang D; Kong X; Jia H; Sun Z; Jia R; Gao P; Poongavanam V; Loregian A; Xu W; Ma X; Ding X; Huang B; Zhan P; Liu X
    J Med Chem; 2018 Nov; 61(22):9976-9999. PubMed ID: 30365885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.
    Yen HL; Ilyushina NA; Salomon R; Hoffmann E; Webster RG; Govorkova EA
    J Virol; 2007 Nov; 81(22):12418-26. PubMed ID: 17855542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.